HSBC Holdings’s Quest Diagnostics DGX Stock Holding History

HSBC Holdings’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,300	Closed	-$1.97M	–	3095
2023 Q4	$1.97M	Hold	14,300	–	–	﹤0.01%	1502
2023 Q3	$1.76M	Hold	14,300	–	–	﹤0.01%	1505
2023 Q2	$2.02M	Hold	14,300	–	–	﹤0.01%	1434
2023 Q1	$1.99M	Buy	+14,300	New	+$2.05M	﹤0.01%	1517
2019 Q1	–	Sell	-1,600	Closed	-$133K	–	2736
2018 Q4	$133K	Buy	+1,600	New	+$150K	﹤0.01%	2524

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

HSBC Holdings's DGX Position: Q2 2026 in Review

HSBC Holdings increased its Quest Diagnostics (DGX) stake by 15% in Q2 2026, buying an estimated $5.86M and bringing the position to 224,986 shares worth $47.8M. The position accounts for 0.02% of the portfolio, ranked #555.

HSBC Holdings first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $96M in Q4 2022. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

HSBC Holdings held 224,986 shares of Quest Diagnostics worth $47.8M as of Q2 2026.
HSBC Holdings bought 29,842 Quest Diagnostics shares in Q2 2026, an estimated $5.86M.
Quest Diagnostics made up 0.02% of HSBC Holdings's portfolio in Q2 2026, its #555 holding.
HSBC Holdings first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
HSBC Holdings's Quest Diagnostics position peaked at $96M in Q4 2022.
1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.